Literature DB >> 25979669

Chikungunya: Evolutionary history and recent epidemic spread.

Scott C Weaver1, Naomi L Forrester2.   

Abstract

Chikungunya virus (CHIKV) has a long history of emergence into urban transmission cycles from its ancestral, enzootic, sylvatic foci in Sub-Saharan Africa, most recently spreading to the Americas beginning in 2013. Since 2004, reemergence has resulted in millions of cases of severe, debilitating and often chronic arthralgia on five continents. Here, we review this history based on phylogenetic studies, and discuss probable future spread and disease in the Americas. We also discuss a series of mutations in the recently emerged Indian Ocean Lineage that has adapted the virus for transmission for the first time by the Aedes albopictus urban mosquito vector, and compare CHIKV to other arboviruses with and without similar histories of urbanization. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World."
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alphavirus; Arbovirus; Arthralgia; Chikungunya; Mosquito; Urbanization

Mesh:

Year:  2015        PMID: 25979669     DOI: 10.1016/j.antiviral.2015.04.016

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  158 in total

Review 1.  Arboviruses and apoptosis: the role of cell death in determining vector competence.

Authors:  Rollie J Clem
Journal:  J Gen Virol       Date:  2016-02-12       Impact factor: 3.891

2.  Genetic Characterization of Northwestern Colombian Chikungunya Virus Strains from the 2014-2015 Epidemic.

Authors:  Juan D Rodas; Tiffany Kautz; Erwin Camacho; Luis Paternina; Hilda Guzmán; Francisco J Díaz; Pedro Blanco; Robert Tesh; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

3.  NF-κB Activation Promotes Alphavirus Replication in Mature Neurons.

Authors:  Jane X Yeh; Eunhye Park; Kimberly L W Schultz; Diane E Griffin
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

4.  Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.

Authors:  April M Clayton
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

Review 5.  Animal Models of Chikungunya Virus Infection and Disease.

Authors:  Nicole N Haese; Rebecca M Broeckel; David W Hawman; Mark T Heise; Thomas E Morrison; Daniel N Streblow
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

Review 6.  Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems.

Authors:  Carlos Pineda; Roberto Muñoz-Louis; Carlo V Caballero-Uribe; Diego Viasus
Journal:  Clin Rheumatol       Date:  2016-08-24       Impact factor: 2.980

7.  Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism.

Authors:  Rana Abdelnabi; Daryl Staveness; Katherine E Near; Paul A Wender; Leen Delang; Johan Neyts; Pieter Leyssen
Journal:  Biochem Pharmacol       Date:  2016-09-21       Impact factor: 5.858

8.  Anticipating Emerging Mosquito-borne Flaviviruses in the USA: What Comes after Zika?

Authors:  Michelle V Evans; Courtney C Murdock; John M Drake
Journal:  Trends Parasitol       Date:  2018-03-15

9.  Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.

Authors:  Ivan Akhrymuk; Tetyana Lukash; Ilya Frolov; Elena I Frolova
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

10.  Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.

Authors:  David W Hawman; Julie M Fox; Alison W Ashbrook; Nicholas A May; Kristin M S Schroeder; Raul M Torres; James E Crowe; Terence S Dermody; Michael S Diamond; Thomas E Morrison
Journal:  Cell Rep       Date:  2016-07-21       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.